Creative Bioarray Launches a Comprehensive Portfolio of High-Performance Human Tumor Cell Lines for Research-Use

Online, August 5, 2013 (Newswire.com) - When researchers try to figure out the mechanism or potential solutions for human tumors, repeatable and controllable systems or models are needed to replace real patients' samples. Therefore, immortalized cancer cell lines-derived from cancers of various organs-are commonly used for this purpose.

The Creative Bioarray tumor cell lines manufactured by its proprietary technologies are excellent test platforms. The tumor cell lines are originally derived from a tumor source, are much easier to culture outside the body, are relatively homogenous in size, can be uniformly distributed in solution have predictable cell surface marker expression, and have much better characterized genetic profiles.

The portfolio includes:

• Astrocytoma/glioblastoma cells
• Oral cancer cells
• Melanoma cells
• Brain/Nerve cancer cells
• Breast cancer cells
• Colorectal cancer cells
• Esophageal cancer cells
• Sarcoma cells
• Leukemia/Lymphoma/Myeloma cells
• Liver cancer cells
• Lung cancer cells
• Bladder (urinary) cancer cells
• Ovarian cancer cells
• Pancreatic cancer cells
• Gastric cancer cells
• Retinoblastoma cells
• Thyroid cancer cells
• Uterine/Cervix cancer cells
• Mesothelioma cells
• Kidney cancer cells
• Others

Creative Bioarray produces the world's most comprehensive list of research-use tumor cells with quality assured.

Creative Bioarray's cells have the following advantages:
Low passage,
Authenticated cell line identity,
Free of contamination.

Creative Bioarray also offers contract research services about various cells, including tumor cells, primary cells, stem cells and transformed cells. We ensure quality as all products go through rigorous QC testing. For more detailed information, please contact [email protected] or visit http://www.creative-bioarray.com/cells.

About Creative Bioarray

Located at Long Island, New York, Creative Bioarray was founded as biomedical company focused on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample.